June 23, 2020 — On June 23, 2020, Stephen M. Hahn, M.D., Commissioner of Food and Drugs, released a statement regarding the United States Food and Drug Administration (FDA) maintaining the pace of meeting its goals on applications for medical products during the pandemic. Hahn stated:

June 22, 2020 — Chronic traumatic encephalopathy (CTE), a neurodegenerative disease caused by repeated head injuries often affecting athletes, can only be diagnosed currently through brain tissue analysis post-mortem.

June 19, 2020 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited and a recognized leader in quantitative imaging analysis for brain tumor diagnosis and treatment, today announced that the MRI DSC perfusion technology, first made commercially available in IB Neuro, earned recognition as the national standard for use in high-grade brain tumors.

June 18, 2020 — QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms. Using advanced deep learning models, the AI-powered diagnostic solution can sort and identify chest X-rays of patients with COVID-19.

June 18, 2020 — Philips announced it has once again joined forces with the American Telemedicine Association (ATA) to help further the adoption of telehealth across the industry, demonstrating its commitment to connecting care across acute, post-acute and home care settings.

June 17, 2020 — Technavio has been monitoring the contrast injectors market and it is poised to grow by $613.47M during 2020-2024, progressing at a CAGR of almost 6% during the forecast period.

June 17, 2020 —"Insights on the Worldwide Handheld Ultrasound Imaging Devices Industry to 2030 - Impact of COVID-19 on the Market" features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of such

June 17, 2020 — RaySearch Laboratories AB launched the latest release of its widely adopted treatment planning system RayStation. The new features and capabilities include two major advances for proton therapy treatment, as well as improved ways of generating plans with machine learning in Plan Explorer and auto-navigated multi-criteria optimization, among others.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now